Targeting ACBP/DBI to Fight Fatty Liver Disease
Acyl-CoA binding protein (ACBP), also known as diazepam-binding inhibitor (DBI), plays a crucial role in controlling autophagy in our bodies. Research has shown that people with metabolic-associated steatohepatitis (MASH) or liver fibrosis have higher levels of ACBP/DBI in their blood compared to he